Literature DB >> 9631350

Severe exacerbation of chronic obstructive airways disease: health resource use in general practice and hospital.

P G Gibson1, J H Wlodarczyk, A J Wilson, A Sprogis.   

Abstract

The objective of this study is to examine the treatment of exacerbations of chronic obstructive airways disease (COAD) in the hospital and in the community setting using a retrospective study of patients admitted to a major teaching hospital combined with a general practice chart audit. The admission records for 248 admissions from 128 patients were reviewed. Most patients (70%) had visited their GP within 2 weeks of admission, antibiotics were prescribed for 30% of the exacerbations while 51% were treated with ingested corticosteroids. During hospitalization, features of infection were present in 64% (n = 159) of exacerbations and 79% (n = 196) received antibiotics. Patients were also treated with nebulized bronchodilators, oxygen and corticosteroids (82%). The median length of stay was 10 days (range 0-55). There was a high readmission rate (70%) at 1 year for exacerbation of COAD during the study period. Exacerbations of COAD frequently demonstrated the clinical features of infection. Treatment in general practice was less intensive than in hospital, and there is a need to reconcile these differences with studies of early therapy with antibiotics and corticosteroids. Although corticosteroids were used less often in general practice, the literature in this area is not conclusive and the evidence supporting guideline recommendations is not explicit. There are opportunities to examine the role of early therapy and early discharge programmes to minimize the cost burden from exacerbations of COAD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631350

Source DB:  PubMed          Journal:  J Qual Clin Pract        ISSN: 1320-5455


  5 in total

Review 1.  Management of an acute exacerbation of copd: are we ignoring the evidence?

Authors:  M K Johnson; R D Stevenson
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

2.  Admissions with chronic obstructive pulmonary disease after publication of national guidelines.

Authors:  M G Kelly; J S Elborn
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

3.  Variations in the management of acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Supna K Sandhu; Jackson Chu; Marko Yurkovich; David Harriman; Catalin Taraboanta; J Mark Fitzgerald
Journal:  Can Respir J       Date:  2013 May-Jun       Impact factor: 2.409

4.  Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease.

Authors:  Oshana Hermiz; Elizabeth Comino; Guy Marks; Kathy Daffurn; Stephen Wilson; Mark Harris
Journal:  BMJ       Date:  2002-10-26

Review 5.  Role of antimicrobial agents in the management of exacerbations of COPD.

Authors:  Sat Sharma; Nicholas Anthonisen
Journal:  Treat Respir Med       Date:  2005
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.